RESUMO
Decision-making capacity in children and adolescents in healthcare requires thorough assessment: the minor's maturity, understanding of the decision, risk of the situation and contextual factors needs to be explored. The intention was to design and validate a test-the Maturtest-to assess the maturity of minors in decision-making processes in healthcare. A reasoning test on moral conflicts for adolescents was designed to infer the degree of maturity of minors applied to decision-making regarding their own health. The test was completed by a sample of 441 adolescents aged from twelve to sixteen, with a corresponding analysis of their psychometric skills to measure feasibility, viability, reliability, validity, and sensitivity to change. Psychometric test results showed viability, reliability, validity, and sensitivity to change. High correlation (correlation index = 0.74) between the test score and the reference method were notable. A high stability was obtained with an intraclass correlation coefficient (r = 0.77). The average response time of the test was twenty-three minutes. This test measures the moral maturity of adolescents. It is presented as an objective, useful, valid, reliable tool, easy to fill out, edit and apply in a healthcare context. It helps to assess the maturity of minors faced with a decision.
Assuntos
Tomada de Decisões , Consentimento Informado por Menores/psicologia , Menores de Idade/psicologia , Desenvolvimento Moral , Inquéritos e Questionários , Adolescente , Criança , Feminino , Humanos , Masculino , Psicometria/instrumentação , Reprodutibilidade dos TestesRESUMO
No disponible
Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Consentimento Livre e Esclarecido/legislação & jurisprudência , Tomada de Decisões , Defesa da Criança e do Adolescente/ética , Autonomia Pessoal , Consentimento dos Pais , Princípios Morais , Competência MentalRESUMO
Desde 2005, los países de África Oriental ya no exigen a los viajeros procedentes de la Unión Europea la certificación internacional de vacunación contra la fiebre amarilla. Ello es debido a la ausencia de casos de enfermedad en el área desde 2003.No obstante, se pueden esgrimir muchos argumentos a favor y en contra de su recomendación según se primen riesgos individuales de efectos secundarios de la vacuna o riesgos de salud pública debidos a no vacunar. En conjunto, el riesgo de enfermedad actualmente permanece muy bajo aunque su potencialidad epidémica es desconocida. En las poblaciones de mayor riesgo de efectos secundarios vacunales, especialmente viajeros de > 60 años, parece razonable una indicación cuidadosa e individualizable (AU)
Since 2005 the countries of Eastern Africa no longer demand to travellers coming from the European Union an international certification of vaccination against yellow fever. This fact is mainly due to the absence of recorded yellow fever cases in the area since 2003. However, many arguments pro and against its recommendation can be used according to prioritize individual risks of secondary vaccine effects or public health hazards due not to vaccinate. Altogether, the disease risk at the moment remains very low although its epidemic potentiality is not known. Among greater risk of vaccine side-effects populations, especially travellers of > 60 years, a careful and personal indication could be considered as the most reasonable attitude (AU)
